Cargando…
Salinomycin treatment reduces metastatic tumor burden by hampering cancer cell migration
BACKGROUND: Tumor spreading is the major threat for cancer patients. The recently published anti-cancer drug salinomycin raised hope for an improved treatment by targeting therapy-refractory cancer stem cells. However, an unambiguous role of salinomycin against cancer cell migration and metastasis f...
Autores principales: | Kopp, Florian, Hermawan, Adam, Oak, Prajakta Shirish, Herrmann, Annika, Wagner, Ernst, Roidl, Andreas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3909296/ https://www.ncbi.nlm.nih.gov/pubmed/24468090 http://dx.doi.org/10.1186/1476-4598-13-16 |
Ejemplares similares
-
Sequential Salinomycin Treatment Results in Resistance Formation through Clonal Selection of Epithelial-Like Tumor Cells()()
por: Kopp, Florian, et al.
Publicado: (2014) -
miR-200c Sensitizes Breast Cancer Cells to Doxorubicin Treatment by Decreasing TrkB and Bmi1 Expression
por: Kopp, Florian, et al.
Publicado: (2012) -
Downregulation of GRK5 hampers the migration of breast cancer cells
por: Sommer, Ann-Katrin, et al.
Publicado: (2019) -
Salinomycin co-treatment enhances tamoxifen cytotoxicity in luminal A breast tumor cells by facilitating lysosomal degradation of receptor tyrosine kinases
por: Sommer, Ann-Katrin, et al.
Publicado: (2016) -
The proto-oncogene KRAS is targeted by miR-200c
por: Kopp, Florian, et al.
Publicado: (2013)